• Birthplace - Camarillo, California
  • BS Biology - University of California San Diego 2005
  • MD - University of California San Diego 2010
  • Residency - Harvard 2016
  • Clinical Focus - Prostate

Dr. Rose is a member of the Genitourinary Disease Team, specializing in novel approaches to the treatment of prostate cancer, and oversees a research lab within the Altman Clinical Translational Research Institute (CTRI).

A dedicated clinical translational researcher, Dr. Rose has published over 30 articles focusing on a variety of topics including health outcomes and novel radiotherapy planning and treatment approaches. His research interests include developing advanced imaging and treatment techniques to improve the efficacy and reduce the side effects of cancer treatments as well as studying health outcomes data to better understand the risks and benefits of treatment and enhance shared decision making with patients and their doctors.